National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 25003 [2023-08626]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 79 / Tuesday, April 25, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
such as sign language interpretation or
other reasonable accommodations, must
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://videocast.
nih.gov/).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: May 16–17, 2023.
Open: May 16, 2023, 12:00 p.m. to 4:30
p.m.
Agenda: Presentation of the NIMH
Director’s Report and discussion of NIMH
programs.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive, Room
160, Bethesda, MD 20892.
Closed: May 17, 2023, 12:00 p.m. to 4:00
p.m.
Agenda: To review and evaluate grant
applications and/or contract proposals.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive, Room
160, Bethesda, MD 20892.
Contact Person: Tracy L. Waldeck, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Mental Health, National
Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Bethesda, MD
20892, (301) 480–6833, tracy.waldeck@
nih.gov.
Any member of the public interested in
presenting oral comments to the committee
must notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice at
least 10 days in advance of the meeting. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/about-
VerDate Sep<11>2014
16:47 Apr 24, 2023
Jkt 259001
nih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.nimh.nih.gov/about/advisory-boardsand-groups/namhc/index.shtml, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: April 19, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–08631 Filed 4–24–23; 8:45 am]
BILLING CODE 4140–01–P
Staff,’ National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Building 33, Room 1N24, 33 North
Drive, Bethesda, MD 20892, 301–761–6362,
Laurie.Lewallen@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 19, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–08626 Filed 4–24–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
25003
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information may be obtained
by communicating with the Technology
Transfer and Intellectual Property
Office, National Institute of Allergy and
Infectious Diseases, 5601 Fishers Lane,
Rockville, MD 20852 by contacting Dr.
Benjamin Hurley at 240–669–5092 or
benjamin.hurley@nih.gov. A signed
Confidential Disclosure Agreement will
be required to receive copies of
unpublished information related to the
invention.
SUPPLEMENTARY INFORMATION:
Technology description follows:
SUMMARY:
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Division of Intramural
Research Board of Scientific Counselors,
NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: June 12–14, 2023.
Time: 7:45 a.m. to 10:55 a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Building 50, Conference Room 1227/
1233, 50 Center Drive, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Division
of Intramural Research Program Support
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Engineered Cell-Penetrating
Monoclonal Antibody for Universal
Influenza Immunotherapy
Description of Technology:
Influenza remains a burden on public
health, as current treatments of viral
infections remain ineffective due to
frequent virus mutations. Many current
influenza treatments rely on targeting
surface viral glycoproteins.
Unfortunately, these glycoproteins are
primary targets of the immune system,
which results in increased selection
E:\FR\FM\25APN1.SGM
25APN1
]]>Agencies
[Federal Register Volume 88, Number 79 (Tuesday, April 25, 2023)]
[Notices]
[Page 25003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08626]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Division of
Intramural Research Board of Scientific Counselors, NIAID.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Allergy and Infectious Diseases, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Division of Intramural Research Board of
Scientific Counselors, NIAID.
Date: June 12-14, 2023.
Time: 7:45 a.m. to 10:55 a.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Building 50, Conference Room 1227/
1233, 50 Center Drive, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Division of Intramural Research
Program Support Staff,' National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Building 33, Room 1N24, 33
North Drive, Bethesda, MD 20892, 301-761-6362,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 19, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-08626 Filed 4-24-23; 8:45 am]
BILLING CODE 4140-01-P
